HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mara Lorenzi Selected Research

Inflammation (Inflammations)

7/2009The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mara Lorenzi Research Topics

Disease

11Diabetic Retinopathy (Retinopathy, Diabetic)
03/2017 - 07/2002
5Hyperglycemia
07/2009 - 07/2002
2Leukostasis
12/2020 - 12/2002
2Vascular Remodeling
03/2017 - 07/2009
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2011 - 12/2010
2Type 2 Diabetes Mellitus (MODY)
07/2011 - 12/2002
1Macular Degeneration (Age-Related Maculopathy)
09/2014
1Macular Edema
07/2011
1Inflammation (Inflammations)
07/2009
1Diabetes Complications
01/2007
1Cataract (Cataracts)
10/2006

Drug/Important Bio-Agent (IBA)

9Retinaldehyde (Retinal)IBA
12/2020 - 07/2002
5Aldehyde Reductase (Aldose Reductase)IBA
01/2007 - 02/2003
3polyolIBA
01/2007 - 02/2003
2Transforming Growth Factors (Transforming Growth Factor)IBA
03/2017 - 07/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2007 - 10/2006
2Streptozocin (Streptozotocin)FDA Link
10/2006 - 09/2004
2Complement System Proteins (Complement)IBA
10/2006 - 12/2002
1Ranibizumab (Lucentis)FDA Link
09/2014
1Biomarkers (Surrogate Marker)IBA
04/2012
1erucylphosphocholineIBA
04/2012
1sorbinilIBA
07/2009
1preemptIBA
07/2009
1Transforming Growth Factor beta (TGF-beta)IBA
07/2009
1EnzymesIBA
01/2007
1FructoseIBA
10/2006
1CP-744809IBA
10/2006
1Sorbitol (Yal)FDA Link
10/2006
1Pharmaceutical PreparationsIBA
12/2005
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2005
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
12/2005
1Galactose (Galactopyranose)FDA LinkGeneric
09/2004
1Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA
12/2002
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
12/2002
1Complement Inactivating AgentsIBA
12/2002
1NF-kappa B (NF-kB)IBA
07/2002

Therapy/Procedure

1Glycemic Control
12/2005